文献速递围术期管理与 ERAS

预测术后急性疼痛的多变量分析

Predicting Acute Pain After Surgery: A Multivariate Analysis.
PubMed 文献 · Ann Surg · 2021-01-01

该研究利用PAIN OUT多国注册数据,对1008例脊柱手术患者进行多变量分析,建立并验证预测术后第1天疼痛的模型(P=8.9E-15)。模型识别出可调整的实践模式:术中至少使用2种非阿片类镇痛药可预测疼痛减轻,而使用超短效阿片类药物则预测疼痛增加。

要点

  • 术中至少使用2种非阿片类镇痛药(如环氧化酶抑制剂、对乙酰氨基酚、奈福泮或安乃近)可提供有意义的疼痛缓解(>30%)。
  • 仅约四分之一患者术中接受了至少2种非阿片类镇痛药。
  • 使用超短效阿片类药物预测术后第1天疼痛增加。

核心结论

  • 术中非阿片类镇痛药种类数与术后第1天疼痛减轻相关,至少2种可提供有意义的疼痛缓解(>30%)。
  • 使用超短效阿片类药物预测术后第1天疼痛增加,提示围术期管理有改进空间。
  • 尽管模型高度显著,但仅解释了观察变异中相对较小的部分。

研究设计与样本

  • 多国注册研究(PAIN OUT)的观察性数据分析。
  • 采用多变量方法建立并验证预测模型,样本为1008例脊柱手术患者。
  • 预测结局为术后第1天(POD1)疼痛。

主要发现

  • 预测模型高度显著(P = 8.9E-15)。
  • 术中至少使用2种非阿片类镇痛药(环氧化酶抑制剂、对乙酰氨基酚、奈福泮或安乃近)可提供>30%的疼痛缓解。
  • 仅四分之一患者术中接受了至少2种非阿片类镇痛药。
  • 使用超短效阿片类药物预测POD1疼痛增加。

关键数值与推荐

  • 至少2种非阿片类镇痛药(环氧化酶抑制剂、对乙酰氨基酚、奈福泮或安乃近)可提供>30%的疼痛缓解。
  • 仅四分之一患者术中接受了至少2种非阿片类镇痛药。

临床怎么用

  • 围术期应考虑联合使用至少2种非阿片类镇痛药以改善术后疼痛。
  • 谨慎使用超短效阿片类药物,可能增加术后第1天疼痛。

局限性

  • 模型虽高度显著,但仅解释观察变异中相对较小的部分。
  • 结果提示当前研究参数之外的因素(如生物学和心理变量)也与术后疼痛相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To identify perioperative practice patterns that predictably impact postoperative pain. BACKGROUND: Despite significant advances in perioperative medicine, a significant portion of patients still experience severe pain after major surgery. Postoperative pain is associated with serious adverse outcomes that are costly to patients and society. METHODS: The presented analysis took advantage of a unique observational data set providing unprecedented detailed pharmacological information. The data were collected by PAIN OUT, a multinational registry project established by the European Commission to improve postoperative pain outcomes. A multivariate approach was used to derive and validate a model predictive of pain on postoperative day 1 (POD1) in 1008 patients undergoing back surgery. RESULTS: The predictive and validated model was highly significant (P = 8.9E-15) and identified modifiable practice patterns. Importantly, the number of nonopioid analgesic drug classes administered during surgery predicted decreased pain on POD1. At least 2 different nonopioid analgesic drug classes (cyclooxygenase inhibitors, acetaminophen, nefopam, or metamizol) were required to provide meaningful pain relief (>30%). However, only a quarter of patients received at least 2 nonanalgesic drug classes during surgery. In addition, the use of very short-acting opioids predicted increased pain on POD1, suggesting room for improvement in the perioperative management of these patients. Although the model was highly significant, it only accounted for a relatively small fraction of the observed variance. CONCLUSION: The presented analysis offers detailed insight into current practice patterns and reveals modifications that can be implemented in today's clinical practice. Our results also suggest that parameters other than those currently studied are relevant for postoperative pain including biological and psychological variables.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Baca Q, Marti F, Poblete B, et al. Predicting Acute Pain After Surgery: A Multivariate Analysis. Ann Surg. 2021. PMID: 31188202. doi:10.1097/SLA.0000000000003400

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。